Within Computational Pathology and Biomarkers, we develop AI-powered solutions to advance patient selection, biomarker development, and clinical decision-making at scale. to drive the development of AI-enabled computational pathology and multimodal biomarkers that directly impact patient selection and drug development across our BioPharma portfolio. Drive the development and application of AI-enabled computational pathology and multimodal biomarkers to support patient selection and decision-making across BioPharmaceuticals. * Lead and collaborate with cross-functional teams to develop AI-driven biomarker signatures for target engagement, patient stratification, and early biological activity * Analyze complex, multimodal datasets (e.g. whole-slide imaging, multiplex assays, imaging and blood biomarkers) to generate meaningful insights
mehr